Millipore Sigma Vibrant Logo
Atención: Nos hemos mudado. Los productos Merck Millipore ya no pueden adquirirse en MerckMillipore.comMás información

05-440 Anti-Cbl Antibody, clone 7G10

05-440
200 µg  
Purchase on Sigma-Aldrich

Ofertas especiales

Descripción

Replacement Information

Ofertas especiales

Tabla espec. clave

Species ReactivityKey ApplicationsHostFormatAntibody Type
H, M, RIP, WB, ICCMPurifiedMonoclonal Antibody
Description
Catalogue Number05-440
Brand Family Upstate
Trade Name
  • Upstate
DescriptionAnti-Cbl Antibody, clone 7G10
Alternate Names
  • Cas-Br-M (murine) ecotropic retroviral transforming sequence
  • Casitas B-lineage lymphoma proto-oncogene
  • Proto-oncogene c-CBL
  • RING finger protein 55
  • Signal transduction protein CBL
  • oncogene CBL2
Background InformationCasitas B-lineage lymphoma (Cbl), is an oncogene which causes pre B-cell lymphomas. It participates in the regulation of cell signaling and has the ability to interact with many proteins such as receptor/non-receptor PTK's, structural proteins, and novel proteins that are not well understood. Diseases associated with Cbl are autoimmune diseases, diabetes, and leukemia. By modifying Cbl's ability to bind to oncogenic proteins, Cbl may be developed into an anti-cancer tool and in the near future used in therapeutic intervention.
References
Product Information
FormatPurified
Control
  • Included Positive Antigen Control: Catalog # 12-305, 3T3/A31 cell lysate. Add 2.5 μl of 2-mercaptoethanol/100 μL of lysate and boil for 5 minutes to reduce the preparation. Load 20μg of reduced lysate per lane for minigels
PresentationPurified IgG1k in 0.1M Tris-Glycine, 0.15M NaCl, 0.05% Sodium Azide, pH7.4
Quality LevelMQ100
Applications
ApplicationThis Anti-Cbl Antibody, clone 7G10 is validated for use in IP, WB, IC for the detection of Cbl.
Key Applications
  • Immunoprecipitation
  • Western Blotting
  • Immunocytochemistry
Application NotesImmunocytochemistry:
5-10 μg/mL of a previous lot showed positive immunostaining for Cbl in 3T3/A31 cells fixed with ice cold Methanol/Ethanol [1:1] for 1 minute.

Immunoprecipitation:
2 μg of a previous lot immunoprecipitated Cbl from 1 mg of a mouse 3T3/A31 cell RIPA lysate, as reported by an independent laboratory.
Biological Information
ImmunogenGST fusion protein corresponding to residues 878-906 of human Cbl
Epitopea.a. 878-906
Clone7G10
ConcentrationPlease refer to the Certificate of Analysis for the lot-specific concentration.
HostMouse
SpecificityAntibody recognizes amino acids 878-906 on human Cbl
IsotypeIgG1κ
Species Reactivity
  • Human
  • Mouse
  • Rat
Antibody TypeMonoclonal Antibody
Entrez Gene Number
Entrez Gene SummaryThe cbl oncogene was first identified as part of a transforming retrovirus which induces mouse pre-B and pro-B cell lymphomas. As an adaptor protein for receptor protein-tyrosine kinases, it positively regulates receptor protein-tyrosine kinase ubiquitination in a manner dependent upon its variant SH2 and RING finger domains. Ubiquitination of receptor protein-tyrosine kinases terminates signaling by marking active receptors for degradation.
Gene Symbol
  • CBL
  • CBL2
  • RNF55
  • C-CBL
Purification MethodProtein G Chromatography
UniProt Number
UniProt SummaryFUNCTION: SwissProt: P22681 # Participates in signal transduction in hematopoietic cells. Adapter protein that functions as a negative regulator of many signaling pathways that start from receptors at the cell surface. Acts as an E3 ubiquitin-protein ligase, which accepts ubiquitin from specific E2 ubiquitin-conjugating enzymes, and then transfers it to substrates promoting their degradation by the proteasome. Recognizes activated receptor tyrosine kinases, including PDGFA, EGF and CSF1, and terminates signaling.
SIZE: 906 amino acids; 99647 Da
SUBUNIT: Associates with NCK via its SH3 domain. The phosphorylated C-terminus interacts with CD2AP via its second SH3 domain. Binds to UBE2L3. Interacts with adapters SLA, SLA2 and with the phosphorylated C-terminus of SH2B2. Interacts with EGFR, SYK and ZAP70 via the highly conserved Cbl-N region. Also interacts with SORBS1 and INPPL1/SHIP2. Interacts with phosphorylated LAT2. May interact with CBLB (By similarity).
SUBCELLULAR LOCATION: Cytoplasm.
DOMAIN: SwissProt: P22681 The RING-type zinc finger domain mediates binding to an E2 ubiquitin-conjugating enzyme. & The N-terminus is composed of the phosphotyrosine binding (PTB) domain, a short linker region and the RING-type zinc finger. The PTB domain, which is also called TKB (tyrosine kinase binding) domain, is composed of three different subdomains: a four-helix bundle (4H), a calcium-binding EF hand and a divergent SH2 domain.
PTM: Phosphorylated on tyrosine residues by EGFR, SYK, FYN and ZAP70 (By similarity). Phosphorylated on tyrosine residues by INSR.DISEASE:SwissProt: P22681 # Can be converted to an oncogenic protein by deletions or mutations that disturb its ability to down-regulate RTKs.
SIMILARITY: Contains 1 CBL N-terminal domain. & Contains 2 EF-hand-like domains. & Contains 1 RING-type zinc finger. & Contains 1 SH2 domain. & Contains 1 UBA domain.
MISCELLANEOUS: This protein has one functional calcium-binding site.
Molecular Weight120kDa
Physicochemical Information
Dimensions
Materials Information
Toxicological Information
Safety Information according to GHS
Safety Information
Product Usage Statements
Quality Assuranceroutinely evaluated by immunoblot on RIPA lysates from human Jurkat, mouse 3T3/A31, TF-1, or FDC-P1/Mac11
Usage Statement
  • Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
Storage and Shipping Information
Storage ConditionsStable for 1 year at 2-8ºC from date of receipt. For maximum recovery of product, centrifuge the vial prior to removing the cap.
Packaging Information
Material Size200 µg
Transport Information
Supplemental Information
Specifications
Global Trade Item Number
Número de referencia GTIN
05-440 04053252336034

Documentation

Anti-Cbl Antibody, clone 7G10 Ficha datos de seguridad (MSDS)

Título

Ficha técnica de seguridad del material (MSDS) 

Anti-Cbl Antibody, clone 7G10 Certificados de análisis

CargoNúmero de lote
Anti-Cbl, clone 7G10 - 16598 16598
Anti-Cbl, clone 7G10 - 17806 17806
Anti-Cbl, clone 7G10 - 18202 18202
Anti-Cbl, clone 7G10 - 2035504 2035504
Anti-Cbl, clone 7G10 - 20519 20519
Anti-Cbl, clone 7G10 - 21658 21658
Anti-Cbl, clone 7G10 - 2199735 2199735
Anti-Cbl, clone 7G10 - 2377368 2377368
Anti-Cbl, clone 7G10 - 23973 23973
Anti-Cbl, clone 7G10 - 2527459 2527459

Referencias bibliográficas

Visión general referenciasPub Med ID
SH3KBP1-binding protein 1 prevents epidermal growth factor receptor degradation by the interruption of c-Cbl-CIN85 complex.
Feng L, Wang JT, Jin H, Qian K, Geng JG
Cell biochemistry and function  29  589-96. doi  2010

Mostrar resumen
21830225 21830225
Cbl-b is a negative regulator of inflammatory cytokines produced by IgE-activated mast cells.
Sonja E Gustin, Christine B F Thien, Wallace Y Langdon
Journal of immunology (Baltimore, Md. : 1950)  177  5980-9  2005

Mostrar resumen
17056522 17056522
A rearrangement of the c-cbl proto-oncogene in HUT78 T-lymphoma cells results in a truncated protein.
Blake, T J and Langdon, W Y
Oncogene, 7: 757-62 (1992)  1992

1565471 1565471